Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

Contributed by: Business Wire

Logo

Tags

Research

Infectious Diseases

Stem Cells

Biotechnology

Health

University

Pharmaceutical

Science

Education

Vanderbilt

More Like This

Parse Biosciences GigaLab to Support Mount Sinai Researchers in Generating One of the Largest Alzheimer's and Parkinson’s Single Cell Datasets

Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually

Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications

Parse Biosciences Launches Single Cell Immune Profiling Products

Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery

Preliminary data from Parse’s chromatin assay showing clustering of mouse brain nuclei based on DNA accessibility profiles. (Graphic: Business Wire)

Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products

Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits

Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies